Cheshire
Senior Member (Voting Rights)
Abstract
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30036-5/fulltext
Depressive disorders are common, costly, have a strong effect on quality of life, and are associated with considerable morbidity and mortality. Effective treatments are available: antidepressant medication and talking therapies are included in most guidelines as first-line treatments. These treatments have changed the lives of countless patients worldwide for the better and will continue to do so in the coming decades. However, although treatments are effective for some people, there is great room for improvement. This Comment highlights ten key statistics relating to the limitations of depression treatment outcomes that we feel warrant greater attention.
A considerable proportion of, particularly child and adolescent, patients show improvement without treatment,1 while a substantial number of patients do not show improvement with treatment (table).5 This finding means that patients are taking treatments with the risk of negative side effects, who either might have recovered without treatment (whether medication or psychotherapies) or might not improve with treatment.4 Moreover, all types of recovery without treatment have been generally grouped together as so-called spontaneous improvement. The multitude of ways in which people might recover have been largely understudied, such as exercise, community engagement, and engagement with nature.6
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30036-5/fulltext
Our lack of knowledge cannot be put down to a scarcity of research in existing treatments. In the past decades, more than 500 randomised trials have examined the effects of antidepressant medications, and more than 600 trials have examined the effects of psychotherapies for depression (although comparatively few are conducted for early-onset depression). However, less than 20% of drug trials and less than 30% of therapy trials have low risk of bias, making the outcomes uncertain. Typically, such trials do not have sufficient statistical power to examine for whom a treatment is effective, resulting in no reliable evidence on who benefits most from which treatment. Also, many different outcome measures are used in treatment research, making it impossible to merge the results of trials without interfering noise. Additionally, longer-term effects are not examined in most trials. Despite more than 1000 trials having been done, very basic questions of real-life importance to people with depression and those trying to help them have not been answered.